Inventor
WILLIAMS THERESA M
US60 patents
⚠️ This page may combine multiple inventors who share the name “WILLIAMS THERESA M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK & CO INC
39 patentsUS5856326AJan 5, 1999
Inhibitors of farnesyl-protein transferase
MERCK & CO INC280 citations99
US6248756B1Jun 19, 2001
Inhibitors of farnesyl-protein transferase
MERCK & CO INC101 citations97
US6080870AJun 27, 2000
Biaryl substituted imidazole compounds useful as farnesyl-protein transferase inhibitors
MERCK & CO INC105 citations97
US5919785AJul 6, 1999
Inhibitors of farnesyl-protein transferase
MERCK & CO INC134 citations97
US5756528AMay 26, 1998
Inhibitors of farnesyl-protein transferase
MERCK & CO INC149 citations97
US5710171AJan 20, 1998
Bisphenyl inhibitors of farnesyl-protein transferase
MERCK & CO INC131 citations97
US5527819AJun 18, 1996
Inhibitors of HIV reverse transcriptase
MERCK & CO INC109 citations97
US5977134ANov 2, 1999
Inhibitors of farnesyl-protein transferase
MERCK & CO INC73 citations96
US5965578AOct 12, 1999
Inhibitors of farnesyl-protein transferase
MERCK & CO INC89 citations96
US5859012AJan 12, 1999
Inhibitors of farnesyl-protein transferase
MERCK & CO INC84 citations96
US5631280AMay 20, 1997
Inhibitors of farnesyl-protein transferase
MERCK & CO INC69 citations96
US6953790B2Oct 11, 2005
CGRP receptor antagonists
MERCK & CO INC36 citations95
US5578629ANov 26, 1996
Benzamide-containing inhibitors of farnesyl-protein transferase
MERCK & CO INC100 citations95
US5534537AJul 9, 1996
Prodrugs of inhibitors of farnesyl-protein transferase
MERCK & CO INC61 citations95
US7390798B2Jun 24, 2008
Carboxamide spirolactam CGRP receptor antagonists
MERCK & CO INC58 citations94
US7205293B2Apr 17, 2007
Benodiazepine spirohydantoin CGRP receptor antagonists
MERCK & CO INC28 citations93
US6387903B1May 14, 2002
Inhibitors of prenyl-protein transferase
MERCK & CO INC34 citations93
US6001835ADec 14, 1999
Inhibitors of farnesyl-protein transferase
MERCK & CO INC22 citations93
US5859015AJan 12, 1999
N-heterocyclic piperazinyl and H-heterocyclic piperazinonyl inhibitors of farnesyl-protein transferase
MERCK & CO INC49 citations93
US5780492AJul 14, 1998
Inhibitors of farnesyl-protein transferase
MERCK & CO INC35 citations93
US5736539AApr 7, 1998
Inhibitors of farnesyl-protein transferase
MERCK & CO INC39 citations93
US7534784B2May 19, 2009
CGRP receptor antagonists
MERCK & CO INC23 citations92
US7476665B2Jan 13, 2009
Benzodiazepine CGRP receptor antagonists
MERCK & CO INC30 citations92
US7452903B2Nov 18, 2008
CGRP receptor antagonists
MERCK & CO INC22 citations92
US7235545B2Jun 26, 2007
CGRP receptor antagonists
MERCK & CO INC22 citations92
US7192954B2Mar 20, 2007
Monocyclic anilide spirohydantoin CGRP receptor antagonists
MERCK & CO INC29 citations92
US6562823B1May 13, 2003
Inhibitors of prenyl-protein transferase
MERCK & CO INC23 citations92
US5204328AApr 20, 1993
Peptides having atrial natriuretic factor activity
MERCK & CO INC30 citations92
US7491713B2Feb 17, 2009
CGRP receptor antagonists
MERCK & CO INC11 citations84
US7196079B2Mar 27, 2007
Benzodiazepine CGRP receptor antagonists
MERCK & CO INC10 citations84
US6610722B2Aug 26, 2003
Inhibitors of prenyl-protein transferase
MERCK & CO INC14 citations84
US5972984AOct 26, 1999
Inhibitors of farnesyl-protein transferase
MERCK & CO INC17 citations83
US7205292B2Apr 17, 2007
CGRP receptor antagonists
MERCK & CO INC9 citations74
US6410534B1Jun 25, 2002
Inhibitors of prenyl-protein transferase
MERCK & CO INC8 citations74
US5057603AOct 15, 1991
Peptides having ANF activity
MERCK & CO INC13 citations74
US6380228B1Apr 30, 2002
Inhibitors of prenyl-protein transferase
MERCK & CO INC6 citations63
US5334591AAug 2, 1994
Tricyclic thienothiopyran carbonic anhydrase inhibitors
MERCK & CO INC2 citations63
US5175284ADec 29, 1992
Tricyclic thienothiopyrans as pharmaceutical intermediates
MERCK & CO INC2 citations63
US5091409AFeb 25, 1992
4-alkylamino-6-(C3-5 -hydrocarbyl)thieno[2,3-B]thiopyran-2-sulfonamide-7,7-dioxides
MERCK & CO INC5 citations63
SHY Therapeutics LLC
10 patentsUS10940139B2Mar 9, 2021
Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
SHY Therapeutics LLC3 citations83
US10870657B2Dec 22, 2020
Compounds for the treatment of cancer and inflammatory disease
SHY Therapeutics LLC4 citations83
US10588894B2Mar 17, 2020
Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
SHY Therapeutics LLC4 citations83
US10221191B2Mar 5, 2019
Compounds for the treatment of cancer and inflammatory disease
SHY Therapeutics LLC5 citations83
US12168668B2Dec 17, 2024
Compounds for the treatment of cancer and inflammatory disease
SHY Therapeutics LLC1 citations72
US11026930B1Jun 8, 2021
Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
SHY Therapeutics LLC2 citations72
US11000515B2May 11, 2021
Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
SHY Therapeutics LLC2 citations72
US10933054B2Mar 2, 2021
Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
SHY Therapeutics LLC2 citations72
US12391705B2Aug 19, 2025
Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
SHY Therapeutics LLC1 citations63
US11560390B2Jan 24, 2023
Compounds for the treatment of cancer and inflammatory disease
SHY Therapeutics LLC0 citations62
MERCK SHARP & DOHME
1 patentShowing the top 50 of 60 patents by PatentIndex Score.